patients with advanced breast carcinoma and no prior chemotherapy were prospectively evaluated to assess the induction capabilities of cyclophosphamide , methotrexate and 5-fluorouracil ( cmf ) , adriamycin and vincristine ( av ) , and cmf plus prednisone ( cmfp ) .
C0025677
cmf
C0055985
cmfp